Format

Send to

Choose Destination
Sleep Med. 2014 Jan;15(1):15-22. doi: 10.1016/j.sleep.2013.09.018. Epub 2013 Oct 26.

Narcolepsy-cataplexy and schizophrenia in adolescents.

Author information

1
Sleep Center, Chang Gung Memorial Hospital and University, Linkou, Taiwan; Child Psychiatry Department, Chang Gung Memorial Hospital and University, Linkou, Taiwan; Psychiatry Department, Chang Gung Memorial Hospital and University, Linkou, Taiwan.
2
Stanford University Sleep Medicine Division, Stanford, CA, USA. Electronic address: cguil@stanford.edu.
3
Psychiatry Department, Chang Gung Memorial Hospital and University, Linkou, Taiwan; Institute of Medical Sciences, Tzu-Chi University, Hualien, Taiwan; Division of Mental Health and Addiction Medicine, Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
4
Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital and University, Linkou, Taiwan.
5
Department of Education, National Chia-Yi University, Chiayi, Taiwan.

Abstract

BACKGROUND:

Despite advances in the understanding of narcolepsy, little information the on association between narcolepsy and psychosis is available, except for amphetamine-related psychotic reactions. Our case-control study aimed to compare clinical differences and analyze risk factors in children who developed narcolepsy with cataplexy (N-C), schizophrenia, and N-C followed by schizophrenia.

METHODS:

Three age- and gender-matched groups of children with N-C schizophrenia (study group), N-C (control group 1), and schizophrenia only (control group 2) were investigated. Subjects filled out sleep questionnaires, sleep diaries, and quality of life scales, followed by polysomnography (PSG), multiple sleep latency tests (MSLT), routine blood tests, HLA typing, genetic analysis of genes of interest, and psychiatric evaluation. The risk factors for schizophrenia also were analyzed.

RESULTS:

The study group was significantly overweight when measuring body mass index (BMI) (P=.016), at narcolepsy onset compared to control group 1, and the study group developed schizophrenia after a mean of 2.55±1.8 years. Compared to control group 2, psychotic symptoms were significantly more severe in the study group, with a higher frequency of depressive symptoms and acute ward hospitalization in 8 out of 10 of the subjects. They also had poorer long-term response to treatment, despite multiple treatment trials targeting their florid psychotic symptoms. All subjects with narcolepsy were HLA DQ B1(∗)0602 positive. The study group had a significantly higher frequency of DQ B1(∗)-03:01/06:02 (70%) than the two other groups, without any significant difference in HLA-DR typing, tumor necrosis factor α (TNF-α) levels, hypocretin (orexin) receptor 1 gene, HCRTR1, and the hypocretin (orexin) receptor 2 gene, HCRTR2, or blood infectious titers.

CONCLUSION:

BMI and weight at onset of narcolepsy as well as a higher frequency of DQ B1(∗)-03:01/06:02 antigens were the only significant differences in the N-C children with secondary schizophrenia; such an association is a therapeutic challenge with long-term persistence of severe psychotic symptoms.

KEYWORDS:

Adolescent; Cataplexy; Chinese and HLA DQ B1-03:01; HLA; Narcolepsy; Schizophrenia

PMID:
24268496
DOI:
10.1016/j.sleep.2013.09.018
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center